Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience

Seminars in Oncology

Volumn 29, Issue 1, 2002, Pages 51-61

  Sugarbaker, Paul H ^a   Acherman, Yair I Z ^a   Gonzalez Moreno, Santiago ^a   Ortega Perez, Gloria ^a   Stuart, O Anthony ^a   Marchettini, Pierre ^a   Yoo, Dal ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CISPLATIN; DOXORUBICIN; PACLITAXEL;

ABDOMINAL PAIN; ASCITES; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURGERY; DIAGNOSTIC ACCURACY; HUMAN; MESOTHELIOMA; PERITONEUM TUMOR; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE;

EID: 0036181163     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.30236     Document Type: Article

References (21)

1. New strategies are needed in diffuse malignant mesothelioma
2. Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965- 1985
3. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature
4. Diffuse pleuml mesothelioma and asbestos exposure in North Western Cape Province
5. Non-asbestos-related malignant mesothelioma. A review
6. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery
7. Differential diagnosis of the simultaneous occurrence of colon carcinoma and peritoneal mesothelioma by immunohistochemistry
8. Early localized peritoneal mesothelioma as an incidental finding at laparoscopy: Report of a case and implications regarding natural history of the disease
9. Phase I trial of intraperitoneal taxol: A Gynecologic Oncology Group study
10. Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer
11. Peritoneal mesothelioma treatment approach based on natural history
12. Results of treatment of 33 patients with peritoneal mesothelioma
13. Peritonectomy procedures
14. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis
15. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis
16. A malignant tumor arising from the endothelium of the peritoneum, and producing mucoid ascitic fluid
17. The pathobiology of the mesothelium Malignant Mesothelioma
18. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma
19. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
20. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP)